Relife Syrup
By Relife
Rx
100ml Syrup in a Bottle

Composition
Guaifenesin(NA) + Ambroxol(NA) + Chlorpheniramine Maleate(NA)

Manufacturer - Leo Pharmaceuticals
LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Danmark

Expires on or after
July, 2027

liver
When using Relife Syrup, it is important to be cautious if you have liver disease. This is because the syrup may require a dose adjustment in such cases. To ensure the safe use of Relife Syrup and to address any concerns related to liver issues, it is advised to consult your doctor for proper guidance.

kidney
Relife Syrup may be safe for kidney disease patients; dose adjustment may not be necessary. Consult your doctor before use. Note May cause excessive sleepiness in end-stage kidney disease patients.

alcohol
When taking Relife Syrup, be cautious as it can lead to increased drowsiness if consumed with alcohol.

driving
When using Relife Syrup, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Relife Syrup may not be safe to use during pregnancy. Studies on animals have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before considering its use. Kindly consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Relife Syrup during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹32.4
₹36
10% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025